Page last updated: 2024-10-25

eflornithine and Goldblatt Syndrome

eflornithine has been researched along with Goldblatt Syndrome in 1 studies

Eflornithine: An inhibitor of ORNITHINE DECARBOXYLASE, the rate limiting enzyme of the polyamine biosynthetic pathway.
eflornithine : A fluoroamino acid that is ornithine substituted by a difluoromethyl group at position 2.

Research Excerpts

ExcerptRelevanceReference
"In this study, we determined whether the persistency of cardiac hypertrophy after chronic vasodilation therapy with minoxidil (minox) was associated with functional or metabolic alterations in hypertensive rat hearts before, during and after an ischemic insult."3.68[Effect of long-term administration of vasodilators and "antitrophic" agents on the structure and function of the heart in hypertensive rats]. ( Carlier, P; Gilles, R; Rorive, G; Smelten, N, 1990)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Carlier, P1
Smelten, N1
Gilles, R1
Rorive, G1

Other Studies

1 other study available for eflornithine and Goldblatt Syndrome

ArticleYear
[Effect of long-term administration of vasodilators and "antitrophic" agents on the structure and function of the heart in hypertensive rats].
    Archives des maladies du coeur et des vaisseaux, 1990, Volume: 83, Issue:8

    Topics: Animals; Cardiomegaly; Drug Therapy, Combination; Eflornithine; Heart Ventricles; Hemodynamics; Hype

1990